Origen Therapeutics

closed

Origen Therapeutics develops therapeutic products from avian transgenic animal technology.

HQ location

Burlingame, United States

Website

Launch date

1997

Employees

Enterprise value

$15—22m

Get premium to view all results

Date	Investors	Amount	Round
Oct 2007	investor	€0.0	round
Aug 2010	N/A	$3.7m	Early VC
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads